The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Yutori wants to bring AI into the workplace by creating a digital personal assistant that can actually do some work for you ...

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Google Ventures and Alphabet, an existing investor, also participated in the round. Top tech companies are racing to position AI-powered offerings as central to their products and services. Startups ...

Google has begun rolling out Gemini 2.5, which the tech giant touts as the “most intelligent AI model” its research lab ...